Comprehensive solutions for haemato-oncology testing

Explore the value of deep molecular analysis in
lymphoid disorders

At Thermo Fisher Scientific, we have developed a wide variety of technologies as advanced solutions to address key challenges in the molecular analysis of haematologic malignancies.

We help you to explore the value of deep molecular analysis using fast next-generation sequencing (NGS), microarrays, and digital PCR in lymphoid diseases.

Listen to our experts to learn how our comprehensive solutions can help simplify and advance your path to test your lymphoid tumour specimen.

Comprehensive solutions for haemato-oncology testing: Explore the value of deep molecular analysis in
lymphoid diseases

Introduction and Keynotes

Chair: Katelyn Gilmour, Sr. Medical Science Liaison,
Thermo Fisher Scientific, Edinburgh, UK

Precision diagnostics in lymphoma – Recent developments and future directions

Presenter: Dr Lesley Ann Sutton, Clinical Senior Lecturer, Trinity College Dublin, Ireland

> View Talk
> Download Slides

The Implementation Of The Oncomine Leader-J Assay For IGHV Somatic Hypermutation Analysis In CLL

Presenter: Dr Robyn Marshall, Consultant Haematologist, Oncolab Diagnostics, Pretoria, South Africa

> View Talk
> Download Slides

Application of genomic arrays to haematological neoplasm research

Presenter: Dr Francesc Solé, Microarrays Unit, Research Group on MDS, Josep Carreras Leukaemia Research Institute, Barcelona, Spain

> View Talk
> Download Slides

 

Oncomine Myeloid MRD NGS Assay

Highly sensitive NGS test for measurable residual disease (MRD) assessment that can identify mutations occurring at very low frequencies.

 

Oncomine Pan-Clonality Assays

Advanced NGS solutions that can sequence multiple B- and T-cell receptor targets in a single reaction for highly sensitive and specific clone detection.

Oncomine Myeloid Assay GX v2

The comprehensive myeloid genomic profiling solution that can deliver an NGS report, covering all key DNA and RNA targets, in as little as one day on the Ion Torrent Genexus System.

Absolute Q dPCR Liquid Biopsy Assays

Applied Biosystems Absolute Q Liquid Biopsy dPCR Assays offer a precise, cost-effective, and rapid method for monitoring response and resistance to treatment by testing for relevant cancer-driver and therapy-resistant mutations.

 

Applied Biosystems GCS3000 Microarray System

The GCS3000 system offers genome-wide copy number microarray solutions in oncology research applications.

 

For Research Use Only.  Not for use in diagnostic procedures.